MARX Biotech , Ltd. Profit Margin

The latest profit margin for 7731.TWO is 5.47% as of June 2026. That compares with -11.53% in the prior-year period — up 147.5% year over year. That is above the Consumer Discretionary sector average of 4.34%. Investors often review this figure alongside MARX Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 7731.TWO's profit margin moved from -11.53% to 5.47% — a 147.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MARX Biotech , Ltd.'s valuation or profitability profile.

Against Consumer Discretionary companies, 7731.TWO currently prints 5.47% for profit margin, while the sector average sits near 4.34%. That is roughly 26.1% above the sector mean. Large gaps often invite a closer look at MARX Biotech , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively MARX Biotech , Ltd. converts resources into returns. At 5.47%, 7731.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -11.53% in the prior-year period — up 147.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 7731.TWO's profit margin (5.47%), review year-over-year change from -11.53%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.